Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
458.89%
Change (1 year)
Categories
Affimed (AFMD) - P/B ratio
P/B ratio as of April 2024 : 0.9477
According to Affimed
's latest financial reports the company has a price-to-book ratio of 0.9477.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Affimed - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.16 | 2.24% |
| 2022-12-31 | 1.13 | -73.67% |
| 2021-12-31 | 4.30 | -33.4% |
| 2020-12-31 | 6.45 | 33.7% |
| 2019-12-31 | 4.82 | 14.04% |
| 2018-12-31 | 4.23 | 176.09% |
| 2017-12-31 | 1.53 | 4.38% |
| 2016-12-31 | 1.47 | -54.41% |
| 2015-12-31 | 3.22 | -16.28% |
| 2014-12-31 | 3.85 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 4.72 | 398.38% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | 11.4 | 1,105.20% | 🇺🇸 USA |
 Agenus
AGEN | -1.67 | -276.36% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0139 | -98.53% | 🇺🇸 USA |